Evidence map›Paper›PMID 32333103›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2020

Efficacy of bevacizumab injection after pterygium excision and limbal conjunctival autograft with limbal fixation suture.

Hee Kyung Yang, Yun Ji Lee, Joon Young Hyon, Kwang Gi Kim, Sang Beom Han

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hee Kyung YangDepartment of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Yun Ji LeeDepartment of Ophthalmology, Kangwon National University School of Medicine, Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon, Kangwon, 200-722, South Korea.
Joon Young HyonDepartment of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
Kwang Gi KimDepartment of Biomedical Engineering, Gachon University College of Medicine, Incheon, South Korea.
Sang Beom HanDepartment of Ophthalmology, Kangwon National University School of Medicine, Kangwon National University Hospital, 156 Baengnyeong-ro, Chuncheon, Kangwon, 200-722, South Korea. m.sangbeom.han@gmail.com.
Kangwon National University Hospital · KRSeoul National University Bundang Hospital · KRGachon University · KR

Funding

Kangwon National University Hospital Grant 2020 Kangwon National University Hospital GrantMinistry of Education NRF-2017R1D1A1B03029983
6 · The paper itself

Abstract

purposeTo determine the efficacy of subconjunctival bevacizumab injection after pterygium excision with limbal conjunctival autograft and limbal fixation suture.

methodsThis retrospective study included a total of 150 eyes of 150 patients with primary pterygium who received three different procedures after pterygium excision, i.e., 49 eyes with limbal conjunctival graft (group A), 48 eyes with limbal conjunctival autograft with limbal fixation suture (group B), and 53 eyes with limbal conjunctival autograft with limbal fixation suture followed by bevacizumab injection (group C). Image analysis was performed using preoperative anterior segment photographs to measure parameters including relative length, relative width, relative area, and vascularity index of pterygium. Recurrence of pterygium was determined at 1 year after surgery, and outcomes were compared between the 3 groups. Risk factors related to recurrence were evaluated using univariate and multivariate analyses.

resultsRecurrence rates after 1 year were 18.4% (9/49), 8.3% (4/48), and 1.9% (1/53) in groups A, B, and C, respectively (P = 0.004). Multivariate analysis showed that patients in group C had significantly reduced risk of recurrence compared with those in group A (P = 0.009), whereas the risk of recurrence was not significantly different between groups A and B (P = 0.227) and groups B and C (P = 0.068), respectively. Among various parameters, higher vascularity index had significant correlation with increased risk of recurrence (P = 0.008).

conclusionsBevacizumab injection after limbal conjunctival autograft and limbal fixation suture may effectively reduce recurrence after pterygium excision. The vascularity of pterygium was associated with a higher risk of recurrence.

Indexed as

RecurrenceAdultAgedAged, 80 and overAngiogenesis InhibitorsAutograftsBevacizumabConjunctivaFemaleFollow-Up StudiesHumansIntravitreal InjectionsLimbus CorneaeMaleMiddle AgedOphthalmologic Surgical ProceduresAngiogenesis InhibitorsBevacizumabReceptors, Vascular Endothelial Growth FactorBevacizumabLimbal conjunctival autograftPterygiumRecurrenceVascularity

Identifiers

PMID32333103
OpenAlexW3018006566

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.